BRISTOL-MYERS SQUIBB COMPANY Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax of $6.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2026-06-30 was $6.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2026-03-31 was $15.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2025-06-30 was -$48.00M, a 500.00% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2025-03-31 was -$37.00M, a 178.72% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2025 was -$73.00M, a 184.88% decline from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2024 was $86.00M, a 616.67% increase from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2023 was $12.00M, a 84.81% decline from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2022 was $79.00M, a 132.35% increase from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.00M 10-Q · filed 2026-07-30 | $22.00M 10-Q · filed 2026-07-30 | ||
| 2026-03-31 | $15.00M 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | -$73.00M 10-K · filed 2026-02-11 | |||
| 2025-06-30 | -$48.00M 10-Q · filed 2026-07-30 | -$85.00M 10-Q · filed 2026-07-30 | -$32.00M derived: sum of 3 quarters · filed 2026-07-30 | -$58.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$37.00M 10-Q · filed 2026-04-30 | $16.00M derived: sum of 2 quarters · filed 2026-04-30 | -$10.00M derived: sum of 3 quarters · filed 2026-04-30 | $2.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $27.00M derived: sum of 2 quarters · filed 2026-02-11 | $39.00M derived: sum of 3 quarters · filed 2026-02-11 | $86.00M 10-K · filed 2026-02-11 |
| 2024-09-30 | -$26.00M 10-Q · filed 2024-10-31 | -$14.00M derived: sum of 2 quarters · filed 2024-10-31 | $33.00M 10-Q · filed 2024-10-31 | $14.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $12.00M 10-Q · filed 2024-07-26 | $59.00M 10-Q · filed 2024-07-26 | $40.00M derived: sum of 3 quarters · filed 2026-02-11 | $58.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $47.00M 10-Q · filed 2025-04-24 | $28.00M derived: sum of 2 quarters · filed 2026-02-11 | $46.00M derived: sum of 3 quarters · filed 2026-02-11 | $62.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -$19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$1.00M derived: sum of 2 quarters · filed 2026-02-11 | $15.00M derived: sum of 3 quarters · filed 2026-02-11 | $12.00M 10-K · filed 2026-02-11 |
| 2023-09-30 | $18.00M 10-Q · filed 2024-10-31 | $34.00M derived: sum of 2 quarters · filed 2024-10-31 | $31.00M 10-Q · filed 2024-10-31 | -$37.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $16.00M 10-Q · filed 2024-07-26 | $13.00M 10-Q · filed 2024-07-26 | -$55.00M derived: sum of 3 quarters · filed 2025-02-12 | $11.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -$3.00M 10-Q · filed 2024-04-25 | -$71.00M derived: sum of 2 quarters · filed 2025-02-12 | -$5.00M derived: sum of 3 quarters · filed 2025-02-12 | $60.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -$68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$2.00M derived: sum of 2 quarters · filed 2025-02-12 | $63.00M derived: sum of 3 quarters · filed 2025-02-12 | $79.00M 10-K · filed 2025-02-12 |
| 2022-09-30 | $66.00M 10-Q · filed 2023-10-26 | $131.00M derived: sum of 2 quarters · filed 2023-10-26 | $147.00M 10-Q · filed 2023-10-26 | $154.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $65.00M 10-Q · filed 2023-07-27 | $81.00M 10-Q · filed 2023-07-27 | $88.00M derived: sum of 3 quarters · filed 2024-02-13 | $101.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $16.00M 10-Q · filed 2023-04-27 | $23.00M derived: sum of 2 quarters · filed 2024-02-13 | $36.00M derived: sum of 3 quarters · filed 2024-02-13 | $39.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $20.00M derived: sum of 2 quarters · filed 2024-02-13 | $23.00M derived: sum of 3 quarters · filed 2024-02-13 | $34.00M 10-K · filed 2024-02-13 |
| 2021-09-30 | $13.00M 10-Q · filed 2022-10-26 | $16.00M derived: sum of 2 quarters · filed 2022-10-26 | $27.00M 10-Q · filed 2022-10-26 | $24.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $3.00M 10-Q · filed 2022-07-27 | $14.00M 10-Q · filed 2022-07-27 | $11.00M derived: sum of 3 quarters · filed 2023-02-14 | $1.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $11.00M 10-Q · filed 2022-04-29 | $8.00M derived: sum of 2 quarters · filed 2023-02-14 | -$2.00M derived: sum of 3 quarters · filed 2023-02-14 | -$6.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$13.00M derived: sum of 2 quarters · filed 2023-02-14 | -$17.00M derived: sum of 3 quarters · filed 2023-02-14 | -$7.00M 10-K · filed 2023-02-14 |
| 2020-09-30 | -$10.00M 10-Q · filed 2021-10-27 | -$14.00M derived: sum of 2 quarters · filed 2021-10-27 | -$4.00M 10-Q · filed 2021-10-27 | -$9.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | -$4.00M 10-Q · filed 2021-07-28 | $6.00M 10-Q · filed 2021-07-28 | $1.00M derived: sum of 3 quarters · filed 2022-02-09 | $9.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $10.00M 10-Q · filed 2021-04-29 | $5.00M derived: sum of 2 quarters · filed 2022-02-09 | $13.00M derived: sum of 3 quarters · filed 2022-02-09 | $12.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $3.00M derived: sum of 2 quarters · filed 2022-02-09 | $2.00M derived: sum of 3 quarters · filed 2022-02-09 | $7.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | $8.00M 10-Q · filed 2020-11-05 | $7.00M derived: sum of 2 quarters · filed 2020-11-05 | $12.00M 10-Q · filed 2020-11-05 | $15.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | -$1.00M 10-Q · filed 2020-08-06 | $4.00M 10-Q · filed 2020-08-06 | $7.00M derived: sum of 3 quarters · filed 2021-02-10 | $9.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $5.00M 10-Q · filed 2020-05-07 | $8.00M derived: sum of 2 quarters · filed 2021-02-10 | $10.00M derived: sum of 3 quarters · filed 2021-02-10 | $20.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $5.00M derived: sum of 2 quarters · filed 2021-02-10 | $15.00M derived: sum of 3 quarters · filed 2021-02-10 | $9.00M 10-K · filed 2021-02-10 |
| 2018-09-30 | $2.00M 10-Q · filed 2019-10-31 | $12.00M derived: sum of 2 quarters · filed 2019-10-31 | $6.00M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $10.00M 10-Q · filed 2019-07-25 | $4.00M 10-Q · filed 2019-07-25 | ||
| 2018-03-31 | -$6.00M 10-Q · filed 2019-04-25 | |||
| 2017-12-31 | -$33.00M 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |